Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy
between this translated document and the Japanese original, the original shall prevail.

January 31, 2024

Consolidated Financial Results
for the Nine Months Ended December 31, 2023
(Under Japanese GAAP)
Company name: Taoka Chemical Co., Ltd.
Listing:
Tokyo Stock Exchange
Securities code: 4113
URL:
https://www.taoka-chem.co.jp
Representative: Yasuaki Sasaki, President
Inquiries:
Yasuhito Katsumoto, General Manager, Business Services OfficeTelephone:+81-6-7639-7400
Scheduled date to file quarterly securities report:
February 9, 2024
Scheduled date to commence dividend payments:–
Preparation of supplementary material on quarterly financial results: None
Holding of quarterly financial results briefing:
None(Yen amounts are rounded down to millions, unless otherwise noted.)

1. Consolidated financial results for the nine months ended December 31, 2023 (from April 1,2023 to December 31, 2023)(1) Consolidated operating results (cumulative)
Sales revenue
Nine months ended

Millions ofyen%

December 31, 2023
December 31, 2022

21,491
22,857

(6.0)
(6.3)

Note: Comprehensive income(Percentages indicate year-on-year changes.)

Operating income

Ordinary income

Net income
attributable toowners of theparent

Millions ofyen

Millions ofyen

Millions ofyen%

833
60.3
520 (77.1)%

885 65.5534 (77.0)

627 74.1
360 (78.5)

For the nine months ended December 31, 2023: ¥658 million [90.0%]
For the nine months ended December 31, 2022: ¥346 million [(79.1)%]

Net income
per share

Diluted net income
per share

Nine months ended
December 31, 2023

YenYen43.81－December 31, 2022

25.16

－%

(2) Consolidated financial position

As ofDecember 31, 2023
March 31, 2023

Equity-to-asset
ratio

Total assets

Net assets

Millions of yen

Millions of yen%

30,03031,06916,971
16,57056.5
53.3

Reference: Equity
As of December 31, 2023:
As of March 31, 2023:¥16,971 million¥16,570 million

2. Cash dividends
Annual dividends per share
SecondThird
Fiscal yearquarter-end
quarter-end
end

First
quarter-end
Fiscal year ended
March 31, 2023
Fiscal year ending
March 31, 2024
Fiscal year endingMarch 31, 2024(Forecast)

Total

Yen

Yen

Yen

YenYen－

18.00

－

9.00

27.00

－

9.00

－
9.00

18.00

Note: Revisions to the forecasts of cash dividends most recently announced: None

3. Consolidated financial forecasts for the fiscal year ending March 31, 2024 (from April 1,2023 to March 31, 2024)(Percentages indicate year-on-year changes.)

Operating income Ordinary income

Net income
attributable toowners of theparent%

Millions ofyen%Millions ofyen

28,500 (5.5)

850

88.4

Sales revenue
Millions ofyen

Full year

Millions ofyen%

900 96.6Net
incomeper share%

yen650 109.2

45.36

Note: Revisions to the forecasts of consolidated financial results most recently announced: Yes
For details of the revisions of consolidated financial results forecasts, please refer to Notice Concerning
Revisions to Full-Year Financial Results Forecasts disclosed on January 31, 2024.

* Notes(1) Changes in significant subsidiaries during the period (changes in specified subsidiaries resulting
in the change in scope of consolidation): None
(2) Adoption of accounting treatment specific to the preparation of quarterly consolidated financialstatements: Yes(3) Changes in accounting policies, changes in accounting estimates, and restatement(i) Changes in accounting policies due to revisions to accounting standards and otherregulations: None(ii) Changes in accounting policies due to other reasons: None(iii) Changes in accounting estimates: None(iv) Restatement: None
(4) Number of issued shares (common shares)(i) Total number of issued shares at the end of the period (including treasury shares)
As of December 31, 2023
As of March 31, 2023

14,440,000 shares
14,440,000 shares(ii) Number of treasury shares at the end of the period
As of December 31, 2023
As of March 31, 2023

111,140 shares
111,140 shares(iii) Average number of shares outstanding during the period (cumulative from the beginning of
the fiscal year)
Nine months ended December 31, 2023
Nine months ended December 31, 2022

14,328,860 shares
14,328,860 shares* Quarterly financial results reports are exempt from quarterly review conducted by certified public
accountants or an audit corporation.
* Proper use of earnings forecasts, and other special matters(Caution regarding forward-looking statements and others)
The forward-looking statements, including financial forecasts, contained in this report are based on
information currently available to the Company and certain assumptions deemed to be reasonable.
Accordingly, they are not intended to be construed as assurance that they will be accomplished in
the future. Note that actual results may differ materially from the forecasts for a number of reasons.

The Taoka Chemical Group’s consolidated sales revenue for the nine months ended December 31,2023, decreased by ¥ 1,365 million compared with the same period of the previous fiscal year, to¥21,491 million. The Group posted operating income of ¥ 833 million, ordinary income of ¥ 885
million and net income attributable to owners of the parent of ¥ 627 million.
The financial results of Taoka Chemical by business segment for the nine months period were as
follows:
Division

Nine Months Ended Nine Months Ended
December 31, 2022 December 31, 2023

ChangeMillions of Composition Millions of Composition Millions of Year-on-yearyen
ratio (%)
yenratio (%)
yenrate (%)

Fine Chemicals

10,465

45.7

9,815

45.7(649)(6.2)

Functional Chemicals
Functional Polymers andAdditives
Chemicals Segment

2,485

10.9

2,527

11.8

41

1.7

9,456

41.4

8,729

40.6

(726)

(7.7)

22,40798.0

21,072

98.1(1,334)

(6.0)

449

2.0

418

1.9

(30)

(6.8)

22,857100.0

21,491100.0(1,365)(6.0)

Analytical Services
Total

Note: The “Analytical Services,” which previously composed the “Others” segment, has been presented as areportable segment because its quantitative importance has increased.

Chemicals Segment
Sales revenue of this segment was ¥21,072 million, a ¥1,334 million decrease compared to thesame period of the previous fiscal year.
Fine Chemicals Division
Though sales of agrochemical intermediates increased, shipments of pharmaceutical intermediates
and monomers for optical resins decreased. As a result, the division sales revenue decreased by¥649 million, to ¥9,815 million.
Functional Chemicals Division
Shipments of adhesives increased. As a result, the division sales revenue increased by ¥41 million
to ¥2,527 million.
Functional Polymers and Additives Division
Shipments of plasticizers and varnish decreased as well as sales prices of varnish decreased
reflecting a decline in raw material prices. As a result, the division sales revenue decreased by ¥726
million, to ¥8,729 million.
Analytical Services Segment
Though sales of measurement and evaluation for working environment increased, sales of asbestos
analysis and of composition and structural analysis decreased. As a result, the segment sales
revenue decreased by ¥30 million, to ¥418 million.